XML 14 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2021
Jun. 30, 2020
Current assets    
Cash and cash equivalents $ 31,474 $ 3,349
Restricted cash 542  
Accounts receivable 112 101
Inventory:    
Raw materials 847 416
Work-in-process 100 38
Finished goods 201 222
Income tax receivable   429
Prepaid expenses and other current assets 396 117
Total current assets 33,672 4,672
Property and equipment, net 82 99
Assets held for disposal   237
Operating leases, right-of-use assets, net 26 851
Other assets   71
Total assets 33,780 5,930
Current liabilities    
Accounts payable 370 239
Payroll related accruals 1,179 433
Accrued expenses and other liabilities 787 627
Income tax payable 2 2
Term note payable - related party 2,500 2,500
Term note payable 512 210
Lease liabilities 32 339
Total current liabilities 5,382 4,350
Term note payable, net of current portion 30 332
Lease liabilities, net of current portion 40 623
Total liabilities 5,452 5,305
Commitments and contingencies (Note 12)
Stockholders’ equity    
Common stock, $0.001 par value, 50,000,000 shares authorized; 25,013,254 and 8,250,286 shares issued at March 31, 2021 and June 30, 2020, respectively; 24,613,338 and 7,850,362 shares outstanding at March 31, 2021 and June 30, 2020, respectively 190,616 190,599
Treasury stock, 399,916 shares at cost at March 31, 2021 and June 30, 2020 (4,129) (4,129)
Additional paid-in capital 47,756 13,934
Accumulated deficit (205,915) (199,779)
Total stockholders’ equity 28,328 625
Total liabilities and stockholders’ equity 33,780 5,930
Convertible Preferred Stock    
Stockholders’ equity    
Convertible preferred stock, $0.001 par value, 2,500,000 shares authorized; 280,898 shares of Series D issued and outstanding at March 31, 2021 and June 30, 2020